EUVIMEDEUVIMED entdecken
Crossref

Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates

Khaoula Balgouthi, Emel Eker, Manaf AlMatar, Osman Albarri, Işil Var

Current Microbiology · 2025

DOI: 10.1007/s00284-025-04582-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Khaoula Balgouthi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Natural and Applied Sciences (Fen Bilimleri Enstitüsü), Çukurova University, Adana, Turkey. khaoulabalghout…. Hauptthemen laut MEDLINE: Clofazimine, Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-tuberculosis activity and resistance were recently refocused since clofazimine (CFZ) had a significant therapeutic benefit in treating multi-drug resistant tuberculosis (MDR-TB). We investigate the resistance of CFZ and genetic mutations in drug-resistant Mycobacterium tuberculosis strains to enhance the diagnosis and treatment of TB patients. CFZ range of CFZ was determined by testing 20 sensitive strains and 80 MDR clinical isolates. The correlation between the patients' treatment history and CFZ resistance was examined. PCR and DNA sequencing were employed to analyze mutations in the Rv0678, Rv1979c, and pepQ genes of CFZ-resistant and susceptible strains. Drug-resistant M. tuberculosis isolates had an 21.25% incidence of CFZ resistance with MIC > 1 mg/L. Neither bedaquiline nor CFZ therapy was the cause of CFZ resistance. It is necessary to perform a CFZ susceptibility test regardless of prior drug exposure. This study reported novel mutation sites associated with CFZ resistance in the pepQ (V85M/R437L/T438N and G605A/G619M/A610Q), Rv0678 (214 C→Tand 407T→C), and Rv1979c (155 A→C, 562 C→T, 1216G→A,724G→A, and 1057T→G) genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClofazimineMycobacterium tuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantMutationDrug Resistance, BacterialHumansMicrobial Sensitivity TestsBacterial ProteinsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

And Rv1979cClofazimine resistanceDrug-resistant tuberculosisPepQRv0678

Substanzen

ClofazimineAntitubercular AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Biotechnology, Institute of Natural and Applied Sciences (Fen Bilimleri Enstitüsü), Çukurova University, Adana, Turkey. khaoulabalghouthi@gmail.com.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Harran University, Sanlıurfa, 63300, Turkey.
  • Biology Department, Faculty of Education and Arts, Sohar University, Sohar, 311, Sultanate of Oman. manafmatar1985@gmail.com.
  • Department of Biotechnology, Institute of Natural and Applied Sciences (Fen Bilimleri Enstitüsü), Çukurova University, Adana, Turkey.
  • Department of Food Engineering, Agricultural Faculty, Çukurova University, Adana, Turkey.

Zitieren

APA

Balgouthi, K., Eker, E., AlMatar, M., Albarri, O., & Var, I. (2025). Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates. Current Microbiology. https://doi.org/10.1007/s00284-025-04582-7

Vancouver

Balgouthi K, Eker E, AlMatar M, Albarri O, Var I. Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates. Current Microbiology. 2025. doi:10.1007/s00284-025-04582-7

BibTeX
@article{Balgouthi2025,
  author = {Balgouthi, Khaoula and Eker, Emel and AlMatar, Manaf and Albarri, Osman and Var, Işil},
  title = {Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates},
  journal = {Current Microbiology},
  year = {2025},
  doi = {10.1007/s00284-025-04582-7}
}
Kostenlos starten →